Cape Bio Pharms, a spin-off company of the biopharming research unit at the University of Cape Town, partnered international biotech companies in the Plants Against Corona initiative. The company sourced the gene sequences for SARS-CoV-2 to develop antigen constructs that could speed up production of antigens, globally. To read the full article, click here.
